Survival Outcomes Following Concomitant Chemoradiation (CRT) for Stage III Non-small Cell Lung Cancer (NSCLC) at Oxford University. (March 2022) - Johnstone, P.; Charlton, P.; Ajzensztejn, D.; Higgins, G.; Stuart, R.; Panakis, N.